Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Goodwill & Intangibles: 2016-2024

Historic Goodwill & Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 6 years, with Dec 2024 value amounting to $2.9 million.

  • Ironwood Pharmaceuticals' Goodwill & Intangibles fell 26.74% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year decrease of 26.74%. This contributed to the annual value of $2.9 million for FY2024, which is 22.32% down from last year.
  • Latest data reveals that Ironwood Pharmaceuticals reported Goodwill & Intangibles of $2.9 million as of FY2024, which was down 22.32% from $3.7 million recorded in FY2023.
  • In the past 5 years, Ironwood Pharmaceuticals' Goodwill & Intangibles ranged from a high of $3.7 million in FY2023 and a low of $2.9 million during FY2024.
  • In the last 2 years, Ironwood Pharmaceuticals' Goodwill & Intangibles had a median value of $3.3 million in 2023 and averaged $3.3 million.
  • Data for Ironwood Pharmaceuticals' Goodwill & Intangibles shows a maximum YoY dropped of 22.32% (in 2024) over the last 5 years.
  • Ironwood Pharmaceuticals' Goodwill & Intangibles (Yearly) stood at $3.7 million in 2023, then decreased by 22.32% to $2.9 million in 2024.